Fairmount Funds Management LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-17 9:00 pm Purchase |
2024-09-13 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 15,556,685 17.950% |
1,600,000 (+11.46%) |
Filing |
| 2024-04-01 6:38 pm Unchanged |
2024-03-28 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 13,956,685 18.640% |
0 (Unchanged) |
Filing |
| 2024-01-24 5:12 pm Purchase |
2024-01-22 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 13,956,685 19.430% |
1,192,292 (+9.34%) |
Filing |
| 2023-11-03 4:30 pm Purchase |
2023-10-30 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 12,764,393 19.990% |
3,571,579 (+38.85%) |
Filing |
| 2022-08-19 4:34 pm Purchase |
2022-08-17 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 9,192,814 19.990% |
5,732,463 (+165.66%) |
Filing |
| 2021-09-23 4:31 pm Purchase |
2021-09-21 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 3,460,351 19.990% |
3,460,351 (New Position) |
Filing |